You have searched for "Biontech"
Showing 1-10 of 1208
KLANG: Selangor Ruler Sultan Sharafuddin Idris Shah and Tengku Permaisuri Selangor Tengku Permaisuri Norashikin have both received their second dose of the Covid-19 vaccine.
Pfizer Inc and its German partner BioNTech SE on Friday asked U.S. regulators to allow the emergency use of their vaccine in adolescents aged 12 to 15.
(Reuters) - Australia said on Friday it had ordered more alternatives for the AstraZeneca vaccine, setting back its vaccination rollout, and Hong Kong delayed deliveries of the shot amid concern about a possible very small risk of rare blood clots.
PARIS (Reuters) - France's top health advisory body in charge of COVID-19 vaccines recommended on Friday that recipients of a first dose of the AstraZeneca shot who are under 55 should receive a second dose with a so-called messenger RNA vaccine.
HONG KONG (The Straits Times/ANN): The authorities here have cut short the compulsory quarantine period in designated hotels for visitors from low-risk countries, including Singapore, from 21 days to 14 from Friday (April 9).
HONG KONG, April 9 (Reuters) - Hong Kong said on Friday it will delay shipments of AstraZeneca’s COVID-19 vaccine this year amid mounting concerns over possible links between the shot and very rare cases of blood clots.
WASHINGTON (Bernama): The Covid-19 Vaccines Global Access (Covax) has so far successfully distributed 38 million doses of three brands of Covid-19 vaccines to more than 100 countries in 42 days, Sputnik quoted the United Nations International Children's Emergency Fund (UNICEF), which oversees the programme, as saying in a press release on Thursday (April 8).
PARIS (Reuters) -More than 10 million people in France have now received a first shot of a COVID-19 vaccine, with the government's target for that number reached a week ahead of schedule, Prime Minister Jean Castex said on Thursday.
(Reuters) - The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc.
PARIS (Reuters) - Several European countries are considering mixing up COVID-19 vaccines for citizens who received a first dose of AstraZeneca's shot, an unprecedented move that highlights challenges for governments struggling to tame fresh rises in infections.